216 related articles for article (PubMed ID: 30231553)
1. STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context.
Segatto I; Baldassarre G; Belletti B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231553
[TBL] [Abstract][Full Text] [Related]
2. The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer.
Hughes K; Watson CJ
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29875329
[TBL] [Abstract][Full Text] [Related]
3. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.
Segatto I; Berton S; Sonego M; Massarut S; Perin T; Piccoli E; Colombatti A; Vecchione A; Baldassarre G; Belletti B
Oncotarget; 2014 Aug; 5(15):6267-79. PubMed ID: 25026286
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation.
Hung AC; Lo S; Hou MF; Lee YC; Tsai CH; Chen YY; Liu W; Su YH; Lo YH; Wang CH; Wu SC; Hsieh YC; Hu SC; Tai MH; Wang YM; Yuan SS
Clin Cancer Res; 2016 Sep; 22(17):4478-90. PubMed ID: 27036136
[TBL] [Abstract][Full Text] [Related]
5. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
6. STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.
Jones LM; Broz ML; Ranger JJ; Ozcelik J; Ahn R; Zuo D; Ursini-Siegel J; Hallett MT; Krummel M; Muller WJ
Cancer Res; 2016 Mar; 76(6):1416-28. PubMed ID: 26719528
[TBL] [Abstract][Full Text] [Related]
7. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
[TBL] [Abstract][Full Text] [Related]
8. Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression.
Jin J; Li Y; Zhao Q; Chen Y; Fu S; Wu J
Cell Commun Signal; 2021 May; 19(1):50. PubMed ID: 33957948
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
[TBL] [Abstract][Full Text] [Related]
10. SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3.
Teng Y; Loveless R; Benson EM; Sun L; Shull AY; Shay C
J Exp Clin Cancer Res; 2021 Aug; 40(1):274. PubMed ID: 34465361
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of STAT3 in breast cancer cells: A review.
Banerjee K; Resat H
Int J Cancer; 2016 Jun; 138(11):2570-8. PubMed ID: 26559373
[TBL] [Abstract][Full Text] [Related]
12. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map.
Huynh J; Chand A; Gough D; Ernst M
Nat Rev Cancer; 2019 Feb; 19(2):82-96. PubMed ID: 30578415
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal effects of STAT5 and STAT3 in breast cancer.
Walker SR; Nelson EA; Zou L; Chaudhury M; Signoretti S; Richardson A; Frank DA
Mol Cancer Res; 2009 Jun; 7(6):966-76. PubMed ID: 19491198
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Liu F; Zhang H; Song H
Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
[TBL] [Abstract][Full Text] [Related]
16. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
18. Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.
Santoni M; Massari F; Del Re M; Ciccarese C; Piva F; Principato G; Montironi R; Santini D; Danesi R; Tortora G; Cascinu S
Expert Opin Investig Drugs; 2015 Jun; 24(6):809-24. PubMed ID: 25746129
[TBL] [Abstract][Full Text] [Related]
19. Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.
Diaz Flaqué MC; Vicario R; Proietti CJ; Izzo F; Schillaci R; Elizalde PV
Steroids; 2013 Jun; 78(6):559-67. PubMed ID: 23178160
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V
Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
